Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. [1]
| Titolo | Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. |
| Publication Type | Journal Article |
| Authors | Zannin, ME [2], Birolo, C [3], Gerloni, VM [4], Miserocchi, E [5], Pontikaki, I [6], Paroli, MP [7], Bracaglia, C [8], Shardlow, A [9], Parentin, F [10], Cimaz, R [11], Simonini, G [12], Falcini, F [13], Corona, F [14], Viola, S [15], De Marco, R [16], Breda, L [17], La Torre, F [18], Vittadello, F [19], Martini, G [20], Zulian, F [21] |
| PubMed ID | 23118110 [22] |